Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
The latest update is out from Active Biotech AB ( (SE:ACTI) ).
Active Biotech AB has announced its upcoming Annual General Meeting scheduled for May 28, 2025, where shareholders will discuss various resolutions including the re-election of board members and the proposal to carry forward the company’s accumulated loss without paying dividends. The meeting will also address the re-election of Öhrlings PricewaterhouseCoopers AB as the auditor, indicating a stable continuity in the company’s governance and financial oversight.
More about Active Biotech AB
Active Biotech AB is a biotechnology company based in Lund, Sweden, focusing on the development of pharmaceuticals for the treatment of autoimmune diseases and cancer. The company is involved in research and development activities aimed at creating innovative therapies to address unmet medical needs.
YTD Price Performance: -21.43%
Average Trading Volume: 26,358
Technical Sentiment Signal: Strong Buy
Current Market Cap: €9.72M
Learn more about ACTI stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue